Chaitan Khosla - Jun 11, 2024 Form 4 Insider Report for Entero Therapeutics, Inc. (ENTO)

Role
Director
Signature
/s/ Sarah Romano, Attorney-in-Fact for Chaitan Khosla
Stock symbol
ENTO
Transactions as of
Jun 11, 2024
Transactions value $
$0
Form type
4
Date filed
6/12/2024, 06:23 PM
Previous filing
Mar 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTO Common Stock Award $0 +24.9K $0.00 24.9K Jun 11, 2024 Direct F1, F2
holding ENTO Common Stock 440 Jun 11, 2024 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 11, 2024, the Reporting Person was granted 24,889 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest in three equal increments on July 1, 2024, September 30, 2024, and December 31, 2024.
F2 Includes unvested RSUs.
F3 Held directly by the Chaitan Khosla Living Trust, in which the Reporting Person serves as the sole Trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.